RecruitingNot ApplicableNCT06061042

Effect of Timed-Restricted Eating on Metabolic Health

The Effect of Timed-Restricted Eating on Insulin Sensitivity, De Novo Lipogenesis and Liver Fat in Subjects With Obesity and Insulin Resistance

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Enrollment

30 participants

Start Date

Oct 1, 2023

Study Type

INTERVENTIONAL

Conditions

Obesity Insulin Resistance Non-Alcoholic Fatty Liver Disease

Summary

We aim to determine the effect of combined isocaloric time restricted eating and meal timing on metabolic health, liver fat, functional brain networks, inflammation, and sleep pattern/quality in subjects with obesity and insulin resistance.

Eligibility

Min Age: 50 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Early time restricted eating and a behavioral approach called Late time restricted eating for people with insulin resistance, non-alcoholic fatty liver disease, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 50 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALEarly time restricted eating

Subjects will follow an isocaloric diet, designed by a dietician. The eating window for the early-TRE group is between 7 AM - 5 PM

BEHAVIORALLate time restricted eating

Subjects will follow an isocaloric diet, designed by a dietician. The eating window for the late-TRE group is between 10 AM - 8 PM

Locations(1)

Amsterdam UMC, location AMC

Amsterdam, North Holland, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06061042

Related Trials

Evaluation of the Care Pathway Offered by the "Chronic Disease Unit" to Obese Patients

NCT065382201 location

A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body

NCT074073481 location

A Study of LY3971297 in Healthy Participants

NCT061482727 locations

Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)

NCT072258161 location

Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity

NCT0749788023 locations